» Articles » PMID: 33335694

Genetic Perturbation of IFN-α Transcriptional Modulators in Human Endothelial Cells Uncovers Pivotal Regulators of Angiogenesis

Abstract

Interferon-α (IFN-α) comprises a family of 13 cytokines involved in the modulation of antiviral, immune, and anticancer responses by orchestrating a complex transcriptional network. The activation of IFN-α signaling pathway in endothelial cells results in decreased proliferation and migration, ultimately leading to suppression of angiogenesis. In this study, we knocked-down the expression of seven established or candidate modulators of IFN-α response in endothelial cells to reconstruct a gene regulatory network and to investigate the antiangiogenic activity of IFN-α. This genetic perturbation approach, along with the analysis of interferon-induced gene expression dynamics, highlighted a complex and highly interconnected network, in which the angiostatic chemokine C-X-C Motif Chemokine Ligand 10 (CXCL10) was a central node targeted by multiple modulators. IFN-α-induced secretion of CXCL10 protein by endothelial cells was blunted by the silencing of Signal Transducer and Activator of Transcription 1 (STAT1) and of Interferon Regulatory Factor 1 (IRF1) and it was exacerbated by the silencing of Ubiquitin Specific Peptidase 18 (USP18). sprouting assay, which mimics angiogenesis, confirmed STAT1 as a positive modulator and USP18 as a negative modulator of IFN-α-mediated sprouting suppression. Our data reveal an unprecedented physiological regulation of angiogenesis in endothelial cells through a tonic IFN-α signaling, whose enhancement could represent a viable strategy to suppress tumor neoangiogenesis.

Citing Articles

Galectin-1-dependent ceRNA network in HRMECs revealed its association with retinal neovascularization.

Yang N, Zhang N, Wang Z, Cao W, He X, Zhang W BMC Genomics. 2023; 24(1):327.

PMID: 37322431 PMC: 10268405. DOI: 10.1186/s12864-023-09352-y.


Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome.

Azzarito G, Henry M, Rotshteyn T, Leeners B, Dubey R Cells. 2023; 12(3).

PMID: 36766731 PMC: 9913637. DOI: 10.3390/cells12030389.


Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade.

Zheng W, Qian C, Tang Y, Yang C, Zhou Y, Shen P Front Immunol. 2022; 13:1035323.

PMID: 36439137 PMC: 9684196. DOI: 10.3389/fimmu.2022.1035323.


Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence.

Azzarito G, Kurmann L, Leeners B, Dubey R Cells. 2022; 11(19).

PMID: 36230929 PMC: 9562882. DOI: 10.3390/cells11192967.


CyTOF Profiling of Zika and Dengue Virus-Infected Human Peripheral Blood Mononuclear Cells Identifies Phenotypic Signatures of Monotype Subsets and Upregulation of the Interferon-Inducible Protein CD169.

Fenutria R, Maringer K, Potla U, Bernal-Rubio D, Evans M, Harris E mSphere. 2021; 6(3):e0050521.

PMID: 34160241 PMC: 8265667. DOI: 10.1128/mSphere.00505-21.

References
1.
Marchisone C, Benelli R, Albini A, Santi L, Noonan D . Inhibition of angiogenesis by type I interferons in models of Kaposi's sarcoma. Int J Biol Markers. 2000; 14(4):257-62. DOI: 10.1177/172460089901400411. View

2.
Santin I, Moore F, Grieco F, Marchetti P, Brancolini C, Eizirik D . USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis. Cell Death Dis. 2012; 3:e419. PMC: 3542594. DOI: 10.1038/cddis.2012.158. View

3.
Gomez D, Reich N . Stimulation of primary human endothelial cell proliferation by IFN. J Immunol. 2003; 170(11):5373-81. DOI: 10.4049/jimmunol.170.11.5373. View

4.
Hsu K, Zhao X, Cheng X, Guan D, Mahabeleshwar G, Liu Y . Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon α-mediated inhibition of angiogenesis. J Biol Chem. 2017; 292(24):10048-10060. PMC: 5473212. DOI: 10.1074/jbc.M116.771071. View

5.
Tompkins W . Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action. J Interferon Cytokine Res. 1999; 19(8):817-28. DOI: 10.1089/107999099313325. View